TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 147 filers reported holding TRANSLATE BIO INC in Q1 2021. The put-call ratio across all filers is 2.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $51,558,000 | +67.0% | 1,872,115 | 0.0% | 5.35% | -6.1% |
| Q1 2021 | $30,871,000 | -36.9% | 1,872,115 | -29.5% | 5.70% | -48.1% |
| Q4 2020 | $48,960,000 | -6.2% | 2,656,517 | -30.7% | 10.98% | +25.1% |
| Q3 2020 | $52,169,000 | -25.8% | 3,833,120 | -2.3% | 8.78% | -51.1% |
| Q2 2020 | $70,282,000 | +79.7% | 3,922,008 | 0.0% | 17.93% | -66.1% |
| Q1 2020 | $39,102,000 | +22.5% | 3,922,008 | 0.0% | 52.94% | +9.8% |
| Q4 2019 | $31,925,000 | -17.9% | 3,922,008 | 0.0% | 48.23% | +300.0% |
| Q3 2019 | $38,867,000 | -21.5% | 3,922,008 | 0.0% | 12.06% | -41.2% |
| Q2 2019 | $49,535,000 | +23.9% | 3,922,008 | 0.0% | 20.50% | +1.6% |
| Q1 2019 | $39,965,000 | +35.9% | 3,922,008 | 0.0% | 20.18% | +30.0% |
| Q4 2018 | $29,415,000 | – | 3,922,008 | – | 15.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |